A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy

被引:6
|
作者
Li, Minying [1 ]
Zhang, Jingjing [1 ]
Zha, Yawen [1 ]
Li, Yani [1 ]
Hu, Bingshuang [1 ]
Zheng, Siming [1 ]
Zhou, Jiaxiong [1 ]
机构
[1] Zhongshan City Peoples Hosp, Dept Oncol Radiotherapy, 2 Sunwen Middle Rd, Zhongshan 528403, Guangdong, Peoples R China
关键词
Xerostomia; Nasopharyngeal carcinoma; Prediction; INTENSITY-MODULATED RADIOTHERAPY; QUALITY-OF-LIFE; NECK-CANCER-PATIENTS; RADIATION-THERAPY; HEAD; OUTCOMES; SALIVA; CHEMORADIATION; TOXICITY; PATTERNS;
D O I
10.1186/s12903-022-02269-0
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background This study was to evaluate the predictors of xerostomia and Grade 3 xerostomia in locoregionally advanced nasopharyngeal carcinoma (NPC) patients receiving radical radiotherapy and establish prediction models for xerostomia and Grade 3 xerostomia based on the predictors. Methods Totally, 365 patients with locoregionally advanced NPC who underwent radical radiotherapy were randomly divided into the training set (n = 255) and the testing set (n = 110) at a ratio of 7:3. All variables were included in the least absolute shrinkage and selection operator regression to screen out the potential predictors for xerostomia as well as the Grade 3 xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The random forest (RF), a decision tree classifier (DTC), and extreme-gradient boosting (XGB) models were constructed. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), area under the curve (AUC) and accuracy were analyzed to evaluate the predictive performance of the models. Results In the RF model for predicting xerostomia, the sensitivity was 1.000 (95%CI 1.000-1.000), the PPV was 0.990 (95%CI 0.975-1.000), the NPV was 1.000 (95%CI 1.000-1.000), the AUC was 0.999 (95%CI 0.997-1.000) and the accuracy was 0.992 (95%CI 0.981-1.000) in the training set. The sensitivity was 0.933 (95%CI 0.880-0.985), the PPV was 0.933 (95%CI 0.880-0.985), and the AUC was 0.915 (95%CI 0.860-0.970) in the testing set. Hypertension, age, total radiotherapy dose, dose at 50% of the left parotid volume, mean dose to right parotid gland, mean dose to oral cavity, and course of induction chemotherapy were important variables associated with the risk of xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy. The AUC of DTC model for predicting xerostomia was 0.769 (95%CI 0.666-0.872) in the testing set. The AUC of the XGB model for predicting xerostomia was 0.834 (0.753-0.916) in the testing set. The RF model showed the good predictive ability with the AUC of 0.986 (95%CI 0.972-1.000) in the training set, and 0.766 (95%CI 0.626-0.905) in the testing set for identifying patients who at high risk of Grade 3 xerostomia in those with high risk of xerostomia. Conclusions An RF model for predicting xerostomia in locoregionally advanced NPC patients receiving radical radiotherapy and an RF model for predicting Grade 3 xerostomia in those with high risk of xerostomia showed good predictive ability.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [41] Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
    Pan, Xin-Bin
    Liu, Yang
    Li, Ling
    Qu, Song
    Chen, Long
    Liang, Shi-Xiong
    Chen, Kai-Hua
    Liang, Zhong-Guo
    Zhu, Xiao-Dong
    AGING-US, 2020, 12 (02): : 1838 - 1847
  • [42] A phase II study of concurrent nimotuzumab and intensity-modulated radiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma.
    Cao, Caineng
    Hu, Qiaoying
    Chen, Xiaozhong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Intensity-modulated radiotherapy combined with sequential cisplatin and fluorouracil chemotherapy for locoregionally advanced nasopharyngeal carcinoma
    Wu, Mingyao
    He, Xiayun
    Hu, Chaosu
    MEDICINE, 2018, 97 (50)
  • [44] Locoregionally advanced nasopharyngeal carcinoma in childhood and adolescence: Analysis of 95 patients treated with combined chemotherapy and intensity-modulated radiotherapy
    Guo, Qiaojuan
    Cui, Xiaofei
    Lin, Shaojun
    Lin, Jin
    Pan, Jianji
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E665 - E672
  • [45] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Feng, Hui-Xia
    Guo, Su-Ping
    Li, Gui-Rong
    Zhong, Wen-Huan
    Chen, Liu
    Huang, Li-Ru
    Qin, Hui-Ying
    MEDICAL ONCOLOGY, 2014, 31 (09) : 1 - 6
  • [46] The next decade of clinical trials in locoregionally advanced nasopharyngeal carcinoma
    Peng, Liang
    Liu, Jin-Qi
    Chen, Yu-Pei
    Ma, Jun
    BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1102):
  • [47] Adjuvant metronomic chemotherapy for locoregionally advanced nasopharyngeal carcinoma Comment
    Kerbel, Robert S.
    Andre, Nicolas
    LANCET, 2021, 398 (10297): : 278 - 279
  • [48] Chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Who really needs it
    Qu, Weiling
    Wang, Xuan
    Qiao, Qiao
    Wang, Yanli
    CANCER MEDICINE, 2023, 12 (06): : 6994 - 7004
  • [49] Toxicity of concurrent chemoradiotherapy with cetuximab for locoregionally advanced nasopharyngeal carcinoma
    Hui-Xia Feng
    Su-Ping Guo
    Gui-Rong Li
    Wen-Huan Zhong
    Liu Chen
    Li-Ru Huang
    Hui-Ying Qin
    Medical Oncology, 2014, 31
  • [50] Sequential chemoradiotherapy with gemcitabine and cisplatin for locoregionally advanced nasopharyngeal carcinoma
    Gu, Mo-Fa
    Liu, Li-Zhi
    He, Long-Jun
    Yuan, Wen-Xin
    Zhang, Rong
    Luo, Guang-Yu
    Xu, Guo-Liang
    Zhang, Hua-Man
    Yan, Chao-Xian
    Li, Jian-Jun
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (01) : 215 - 223